{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:09:35Z","timestamp":1789016975542,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,18]],"date-time":"2027-08-18T00:00:00Z","timestamp":1818547200000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21DA062400"],"award-info":[{"award-number":["R21DA062400"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DA007237-35"],"award-info":[{"award-number":["T32DA007237-35"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neuro.2026.103547","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:53:42Z","timestamp":1786722822000},"page":"103547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Xylazine, veterinary anesthetic and recreational drug adulterant, reduces cephalic regeneration and alters defensive responding in planarians"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0286-184X","authenticated-orcid":false,"given":"Amy D.","family":"Stringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana","family":"Dachepalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Rawls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2026.103547_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2025.115155","article-title":"RAP-103, a multi-chemokine receptor antagonist, displays anxiolytic-like effects and normalizes methamphetamine abstinence-induced behaviors in planarians","volume":"304","author":"Abiru","year":"2026","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuro.2026.103547_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/ADM.0000000000001423","article-title":"Withdrawal signs and symptoms among patients positive for fentanyl with and without xylazine","volume":"19","author":"Alexander","year":"2025","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.neuro.2026.103547_bib3","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2105\/AJPH.2022.306881","article-title":"Xylazine and overdoses: trends, concerns, and recommendations","volume":"112","author":"Alexander","year":"2022","journal-title":"Am. J. Public. Health"},{"key":"10.1016\/j.neuro.2026.103547_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0742-8413(83)90142-1","article-title":"Effects of dopaminergic agents on monoamine levels and motor behaviour in planaria","volume":"74","author":"Algeri","year":"1983","journal-title":"Comp. Biochem. Physiol. C. Comp. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuro.2026.103547_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bbalip.2019.01.011","article-title":"Insights into the histology of planarian flatworm Phagocata gracilis based on location specific, intact lipid information provided by GCIB-ToF-SIMS imaging","volume":"1864","author":"Angerer","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"10.1016\/j.neuro.2026.103547_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.neuropharm.2016.02.010","article-title":"Modulatory effects of the basolateral amygdala alpha2-adrenoceptors on nicotine-induced anxiogenic-like behaviours of rats in the elevated plus maze","volume":"105","author":"Bashiri","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2026.103547_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2024.100155","article-title":"Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism","volume":"11","author":"Bedard","year":"2024","journal-title":"Addict. Neurosci."},{"key":"10.1016\/j.neuro.2026.103547_bib8","doi-asserted-by":"crossref","DOI":"10.1242\/bio.060480","article-title":"Neurophysiological measurements of planarian brain activity: a unique model for neuroscience research","volume":"13","author":"Benita","year":"2024","journal-title":"Biol. Open."},{"key":"10.1016\/j.neuro.2026.103547_bib9","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/pan.14279","article-title":"Preoperative anxiety in preschool children: a randomized clinical trial comparing midazolam, clonidine, and dexmedetomidine","volume":"31","author":"Bromfalk","year":"2021","journal-title":"Paediatr. Anaesth."},{"key":"10.1016\/j.neuro.2026.103547_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/biom15111542","article-title":"Within- and between-subject analyses of the effects of chronic xylazine on negative phototaxis in two planarian species","volume":"15","author":"Byrne","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuro.2026.103547_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.112450","article-title":"Effects of xylazine on naloxone-precipitated fentanyl withdrawal in male and female rats","volume":"264","author":"Carlson","year":"2024","journal-title":"Drug. Alcohol. Depend."},{"key":"10.1016\/j.neuro.2026.103547_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.physbeh.2019.04.003","article-title":"Predator odor produces anxiety-like behavioral phenotype in planarians that is counteracted by fluoxetine","volume":"206","author":"Cho","year":"2019","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuro.2026.103547_bib13","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00213-023-06390-y","article-title":"Xylazine effects on opioid-induced brain hypoxia","volume":"240","author":"Choi","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuro.2026.103547_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.scitotenv.2019.04.234","article-title":"Exposure to Roundup(R) affects behaviour, head regeneration and reproduction of the freshwater planarian Girardia tigrina","volume":"675","author":"C\u00f3rdova L\u00f3pez","year":"2019","journal-title":"Sci. Total. Environ."},{"key":"10.1016\/j.neuro.2026.103547_bib15","article-title":"Use of clonidine in the management of opiate withdrawal in community patients","volume":"7","author":"David Kelsey","year":"2021","journal-title":"BJPsych Open."},{"key":"10.1016\/j.neuro.2026.103547_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314619","article-title":"Molecular insights and clinical outcomes of drugs of abuse adulteration: new trends and new psychoactive substances","volume":"23","author":"Di Trana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuro.2026.103547_bib17","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.7326\/M23-2001","article-title":"Xylazine adulteration of the heroin-fentanyl drug supply: a narrative review","volume":"176","author":"D'orazio","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuro.2026.103547_bib18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuroscience.2018.06.029","article-title":"Mu opioid receptor agonist DAMGO produces place conditioning, abstinence-induced withdrawal, and naltrexone-dependent locomotor activation in planarians","volume":"386","author":"Dziedowiec","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2026.103547_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11916-024-01211-z","article-title":"Xylazine: a drug adulterant of clinical concern","volume":"28","author":"Edinoff","year":"2024","journal-title":"Curr. Pain. Headache Rep."},{"key":"10.1016\/j.neuro.2026.103547_bib20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/ADM.0000000000000955","article-title":"Management of xylazine withdrawal in a hospitalized patient: a case report","volume":"16","author":"Ehrman-Dupre","year":"2022","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.neuro.2026.103547_bib21","series-title":"PhD","article-title":"Energy metabolism and the control of stem cell proliferation in planarians","author":"Frank","year":"2020"},{"key":"10.1016\/j.neuro.2026.103547_bib22","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1073\/pnas.88.16.7338","article-title":"Planarian homeobox genes: cloning, sequence analysis, and expression","volume":"88","author":"Garcia-Fern\u00e0ndez","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuro.2026.103547_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2885.1981.tb00715.x","article-title":"The pharmacokinetics of xylazine hydrochloride: an interspecific study","volume":"4","author":"Garcia-Villar","year":"1981","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.neuro.2026.103547_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13276","article-title":"An insight into planarian regeneration","volume":"55","author":"Ge","year":"2022","journal-title":"Cell. Prolif."},{"key":"10.1016\/j.neuro.2026.103547_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002024.pub5","article-title":"Alpha(2)-adrenergic agonists for the management of opioid withdrawal","author":"Gowing","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuro.2026.103547_bib26","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMp2303120","article-title":"Xylazine - Medical and Public Health Imperatives","volume":"388","author":"Gupta","year":"2023","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.neuro.2026.103547_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/jat\/25.4.245","article-title":"Severe intoxication with the veterinary tranquilizer xylazine in humans","volume":"25","author":"Hoffmann","year":"2001","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuro.2026.103547_bib28","article-title":"Xylazine induced skin necrosis","author":"Howard-Williams","year":"2024","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.neuro.2026.103547_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/00952990.2022.2144743","article-title":"Sublingual dexmedetomidine (BXCL501) reduces opioid withdrawal symptoms: findings from a multi-site, phase 1b\/2, randomized, double-blind, placebo-controlled trial","volume":"49","author":"Jones","year":"2023","journal-title":"Am. J. Drug. Alcohol. Abus."},{"key":"10.1016\/j.neuro.2026.103547_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.beproc.2023.104894","article-title":"Conditioned place avoidance in the planaria Schmidtea mediterranea: a pre-clinical invertebrate model of anxiety-related disorders","volume":"210","author":"Jordan","year":"2023","journal-title":"Behav. Process."},{"key":"10.1016\/j.neuro.2026.103547_bib31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jat\/bkac049","article-title":"Xylazine: pharmacology review and prevalence and drug combinations in forensic toxicology casework","volume":"46","author":"Kacinko","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuro.2026.103547_bib32","article-title":"The XYZs of xylazine: management of withdrawal and complications","author":"Khaddage","year":"2025","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.neuro.2026.103547_bib33","article-title":"Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats","author":"Khatri","year":"2023","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuro.2026.103547_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.japh.2019.10.004","article-title":"Lofexidine versus clonidine for mitigation of opioid withdrawal symptoms: a systematic review","volume":"60","author":"Kuszmaul","year":"2020","journal-title":"J. Am. Pharm. Assoc. (2003)"},{"key":"10.1016\/j.neuro.2026.103547_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0306-4522(02)00185-9","article-title":"Behvaioral and neurochemical characterization of alpha2A adrenergic receptor knockout mice","volume":"113","author":"Lahdesmaki","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2026.103547_bib36","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.15585\/mmwr.mm7348a2","article-title":"Detection of illegally manufactured fentanyls and carfentanil in drug overdose deaths \u2014 United States, 2021\u20132024","volume":"73","author":"Tanz","year":"2024","journal-title":"CDC Morb. Mortal. Wkly. Report. (MMWR)"},{"key":"10.1016\/j.neuro.2026.103547_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-2999(81)90602-6","article-title":"Clonidine analgesia and suppression of operant responding Dissociation of mechanism","volume":"69","author":"McCleary","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuro.2026.103547_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.devcel.2016.07.012","article-title":"Egf signaling directs neoblast repopulation by regulating asymmetric cell division in planarians","volume":"38","author":"Lei","year":"2016","journal-title":"Dev. Cell."},{"key":"10.1016\/j.neuro.2026.103547_bib39","article-title":"Xylazine adulteration in illicit fentanyl: a threat to public health","author":"Marshall","year":"2024","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.neuro.2026.103547_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/ADM.0000000000001245","article-title":"Xylazine-associated wounds: clinical experience from a low-barrier wound care clinic in Philadelphia","volume":"18","author":"Mcfadden","year":"2024","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.neuro.2026.103547_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156345","article-title":"Clues from planarians about interleukin-17A and stress that result from light avoidance: IL-17A antagonists reduce defensive responding in flatworms","volume":"170","author":"Milton","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.neuro.2026.103547_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2022.113933","article-title":"Energy drink produces aversive effects in planarians","volume":"255","author":"Mokkarala","year":"2022","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuro.2026.103547_bib43","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.neuroscience.2008.03.026","article-title":"Identification of glutamic acid decarboxylase gene and distribution of GABAergic nervous system in the planarian Dugesia japonica","volume":"153","author":"Nishimura","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2026.103547_bib44","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMicm2303601","article-title":"Xylazine-associated skin injury","volume":"388","author":"O'neil","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuro.2026.103547_bib45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0306-3623(89)90197-3","article-title":"Xylazine-evoked depression of rat cerebral cortical neurons: a pharmacologocal study","volume":"20","author":"O'regan","year":"1989","journal-title":"General. Pharmacol."},{"key":"10.1016\/j.neuro.2026.103547_bib46","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s11064-015-1512-6","article-title":"Evidence of nicotine-induced, curare-insensitive, behavior in planarians","volume":"40","author":"Pag\u00e1n","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuro.2026.103547_bib47","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neulet.2006.08.073","article-title":"Toxicity and behavioral effects of dimethylsulfoxide in planaria","volume":"407","author":"Pag\u00e1n","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2026.103547_bib48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pbb.2007.12.008","article-title":"Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones","volume":"89","author":"Pag\u00e1n","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuro.2026.103547_bib49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2009.05.022","article-title":"A cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms","volume":"615","author":"Pag\u00e1n","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuro.2026.103547_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160247","article-title":"Adaptive benefits of storage strategy and dual AMPK\/TOR signaling in metabolic stress response","volume":"11","author":"Pfeuty","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuro.2026.103547_bib51","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2018.09.021","article-title":"The cellular and molecular basis for planarian regeneration","volume":"175","author":"Reddien","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neuro.2026.103547_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109816","article-title":"Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: a comparison to lofexidine","volume":"245","author":"Sadek","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuro.2026.103547_bib53","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pbb.2007.09.013","article-title":"Alpha-2 agonists decrease expression of morphine-induced conditioned place preference","volume":"88","author":"Samini","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuro.2026.103547_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.162556","article-title":"Microplastics altered cellular responses, physiology, behaviour, and regeneration of planarians feeding on contaminated prey","volume":"875","author":"Silva","year":"2023","journal-title":"Sci. Total. Environ."},{"key":"10.1016\/j.neuro.2026.103547_bib55","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/FBP.0000000000000860","article-title":"Xylazine and opioid coadministration enhances stereotyped movements in planarians","volume":"36","author":"Stringer","year":"2025","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuro.2026.103547_bib56","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/add.16388","article-title":"Clinical considerations for the management of xylazine overdoses and xylazine-related wounds","volume":"119","author":"Sue","year":"2024","journal-title":"Addiction"},{"key":"10.1016\/j.neuro.2026.103547_bib57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/FBP.0000000000000814","article-title":"The effects of xylazine on locomotion and motor behaviour in a planarian model","volume":"36","author":"Taylor","year":"2025","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuro.2026.103547_bib58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jneumeth.2017.10.010","article-title":"PLDT (planarian light\/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects","volume":"293","author":"Zewde","year":"2018","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuro.2026.103547_bib59","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2478\/jvetres-2018-0017","article-title":"Xylazine regulates the release of glycine and aspartic acid in rat brain","volume":"62","author":"Zhang","year":"2018","journal-title":"J. Vet. Res."},{"key":"10.1016\/j.neuro.2026.103547_bib60","article-title":"Xylazine activates adenosine monophosphate-activated protein kinase pathway in the central nervous system of rats","volume":"11","author":"Zhou","year":"2016","journal-title":"PloS One"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X26001683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X26001683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:28:30Z","timestamp":1789014510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X26001683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"alternative-id":["S0161813X26001683"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2026.103547","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Xylazine, veterinary anesthetic and recreational drug adulterant, reduces cephalic regeneration and alters defensive responding in planarians","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2026.103547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103547"}}